The Athlete Biological Passport: a ‘magic bullet’ for EPO detection? Part 2 of 2
The anti-doping community has taken note of these criticisms (see part 1) and in 2000 WADA approved its operating guidelines for the Athlete Biological Passport (ABP) marking a return to indirect testing methods and a change of analytical focus from urine to blood.
Continue reading this article...
Already a member? Sign in
Get access to all of the expert analysis and commentary at LawInSport including articles, webinars, conference videos and podcast transcripts. Find out more here.
- Tags: Anti-Doping | Athlete Biological Passport (ABP) | Court of Arbitration for Sport (CAS) | Erythropoietin | UCI | US Anti-Doping Agency (USADA) | World Anti-Doping Agency (WADA)
About the Author
Emma is a trainee solicitor in Squire Patton Boggs’ sports litigation department who has completed seats in corporate, international dispute resolution and a secondment to Chelsea Football Club. During her traineeship Emma has, from a sporting perspective, assisted with the sale of a Championship football club and the provision of advice to various International Federations and Premier League football clubs.